STAT

Opinion: The real public health emergency of international concern: the DRC

To stop the Ebola outbreak in the DRC from spiraling out of control, it must be seen as a symptom of a deeper public health crisis in the country.
Freshly dug graves are seen in Beni, a city in the Democratic Republic of the Congo. In nearly a year, more than 1,700 people in the DRC have died of Ebola.

The decision to declare the yearlong Ebola outbreak in the Democratic Republic of the Congo as a public health emergency of international concern (PHEIC) will almost certainly help focus the world’s attention on this deepening crisis. But while it is already bringing much-needed donor funds and international assistance, the danger is that this decision could have unintended repercussions that further hinder the emergency response on the ground.

If this gamble is to be successful, then the response will need to go beyond the immediate Ebola crisis and address much deeper long-term issues that have plagued the region — issues that ultimately

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks